Is Cellebrite DI Ltd. overvalued or undervalued?

As of 14 November 2025, the valuation grade for Cellebrite DI Ltd. moved from fair to attractive, indicating a more favorable outlook for the company. Based on the available metrics, Cellebrite appears to be undervalued, particularly given its Price to Book Value of 10.89 and an EV to EBITDA ratio of 50.27, which, while high, suggests potential growth relative to its current valuation. The EV to Sales ratio stands at 8.48, further supporting the notion that the company may be undervalued compared to its peers.
In comparison to its industry, Cellebrite's P/E ratio is not applicable due to its loss-making status, but it is noteworthy that Clearwater Analytics Holdings, Inc. has a P/E of 12.49, while SolarWinds Corp. shows a P/E of 25.03, highlighting the disparity in valuation among peers. Although specific return data for Cellebrite is not available, the overall market sentiment reflected in the S&P 500 suggests that the stock's recent performance could align with a positive valuation narrative.